Integrated approach to the treatment of cough, inside and out. Features of the use of Eucabal
- Authors: Ovchinnikov A.Y.1, Miroshnichenko N.A1, Smirnov I.V1
-
Affiliations:
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry
- Issue: Vol 26, No 5 (2019)
- Pages: 133-137
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/297683
- DOI: https://doi.org/10.18565/pharmateca.2019.5.133-137
- ID: 297683
Cite item
Open Access
Access granted
Abstract
Cough is one of the most widespread respiratory symptoms, which is manifested in people, regardless of age, place of residence and social status; it often affects the lifestyle and activity of people. For example, in European countries over 30% of the population aged 23 to 50 years suffer from coughing, and the number of such patients increases every year. The urgency of the problem of treating cough is associated with the incorrect treatment of inflammatory diseases of the nasal cavity and upper respiratory tract, which leads to the development of complications and chronization of the process. At the requisition of the World Health Organization (WHO), over-the-counter drugs must meet the following requirements: the drug must be well known, often used in medical practice, be safe for children and not have a toxic effect on the human body. As an example of modern plant products, drug Eucabal can be considered. The article shows the values of the effectiveness of the drug Eucabal in the form of syrup and balsam. This drug may be recommended for the treatment of dry or wet cough. To achieve the best result, the drug should be used at the first sign of coughing.
Keywords
Full Text
About the authors
Andrey Yu. Ovchinnikov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Email: lorent1@mail.ru
MD, Professor at the Department of Otorhinolaryngology
N. A Miroshnichenko
A.I. Yevdokimov Moscow State University of Medicine and DentistryDepartment of Otorhinolaryngology
I. V Smirnov
A.I. Yevdokimov Moscow State University of Medicine and DentistryDepartment of Otorhinolaryngology
References
- Афанасьева И.А. Комплексная терапия ОРВИ. РМЖ. 2007;15(18):125-30.
- Рязанцев С.В. Принципы этиопатогенетической терапии острых синуситов (методические рекомендации). СПб., 2013. 40 с.
- Белов Б.С. Инфекции верхних дыхательных путей и ЛОР-органов. Рациональная антимикробная фармакотерапия / Под ред. В.П. Яковлева, С.В. Яковлева. М., 2003. С. 208-9.
- Green H., Glassock R., Kelly M. (Ed.) Introduction to clinical medicine. Ontario: B.C. Decker Inc., 1991. 794 p.
- Shimizu T., Niizeki H., Takeuchi O. Induction of macrophage migration inhibitory factor precedes the onset of acute tonsillitis. Mediators Inflamm. 2004;13(4):293-95.
- Kehrl W., Sonnemann U., Dethlefsen U. Therapy foracute nonpuulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope. 2004;114(4):738-42. doi: 10.1097/00005537-200404000- 00027.
- Ярощук Л.Б. Растительные препараты при кашле у детей: целесообразность применения и клиническая эффективность: Сборник трудов Национального института фтизиатрии и пульмонологии им. Ф.Г. Яновского АМН Украины. Киев, 2007. С. 19-22.
- Привалова Т.Е., Шадрин С.А., Шадрина Э.М. Новые фитопрепараты при лечении кашля у детей младших возрастных групп с острыми респираторными заболеваниями. Вопросы современной педиатрии. 2007;6(4):128-
- Елкина Т.Н., Кондюрина Е.Г., Грибанова О.А. и др. Коделак Фито в терапии кашля у детей с остры -ми респираторными инфекциями. Вопросы практической педиатрии. 2006;1(5):36-9.
- Синева Т., Кузнецова А. Сиропы для лечения кашля. Новая аптека. 2016;11:36-41.
- Packman E.W., London S.J. The utility of artificially induced coudh as a clinical model for evaluating the antitussive effects of aromatics delivered by inunction. Eur Respir J. 1980;61(110):101-109.
- Saldon A.E., Lamson D.W. Immune-modifying and antimicrobial effect s of eucalyptus oil and simple inhalation devices. Alternative Med. Rev. 2010;15(1);123-27.
- Basch E., Ulbricht C., Hammerness P., Bevins A., Sollars D. Thyme (Thymus vulgaris L.), Thymol. J. Herbal Pharmacother. 2004;4(1):49-67.
- Tohidpour A., Sattari M., Omidbaigi R., et al. Antibacterial effect of essential oils from two medicinal plants against methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine. 2010;17(2):142-45. Doi: 10.1016/ J. phymed.2009.05.007.
- Yanishlieva N.V., Marinova E.M., Gordon M.H., Raneva VG. Antioxidant activity and mechanism of action of thymol and carvacrol in two lipid systems. Food Chemistry. 1999;64:59-66.
- Эвкабал сироп от кашля и Эвкабал Бальзам С. http://2 med.org/index.php. Интернет-ресурс.
Supplementary files
